SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

Oppenheimer Downgrades Portola Pharmaceuticals to Perform, Lowers Price Target to $17

Oppenheimer downgrades Portola Pharmaceuticals (NASDAQ:PTLA) from Outperform to Perform and lowers the price target from $40 to $17.

Benzinga · 01/10/2020 12:35

Oppenheimer downgrades Portola Pharmaceuticals (NASDAQ:PTLA) from Outperform to Perform and lowers the price target from $40 to $17.